CorMedix Inc (CRMD)

NASDAQ
4.630
+0.050(+1.09%)
After Hours
4.630
0.000(0.00%)
- Real-time Data
  • Volume:
    98,929
  • Bid/Ask:
    4.600/4.850
  • Day's Range:
    4.505 - 4.660

CRMD Overview

Prev. Close
4.58
Day's Range
4.505-4.66
Revenue
200K
Open
4.64
52 wk Range
4.3-18.8
EPS
-0.73
Volume
98,929
Market Cap
176.24M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
200,768
P/E Ratio
-
Beta
2.4
1-Year Change
-47.62%
Shares Outstanding
38,064,605
Next Earnings Date
Mar 17, 2022
What is your sentiment on CorMedix Inc?
or
Market is currently closed. Voting is open during market hours.

CorMedix Inc Company Profile

Employees
35

CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's primary focus is on the development of its product candidate, DefenCath. The Company has in-licensed the rights to develop and commercialize its product candidate DefenCath. The DefenCath is a novel anti-infective solution intended for the reduction of catheter-related infections in patients requiring central venous catheters in clinical settings such as hemodialysis, total parenteral nutrition, and oncology. DefenCath product is available in Europe and other territories under the brand name Neutrolin.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuySellStrong SellStrong Sell
Technical IndicatorsStrong BuyBuySellStrong SellStrong Sell
SummaryStrong BuyBuySellStrong SellStrong Sell
  • it's time to add more? It was not essential medical reasons for disapproval but only technical
    0
    • It feels so. I don't see how whatever the manufacturing issue is, won't get solved. Obviously it will delay things though.
      0
  • :(
    0
    • Looks like 25$ after 28th Feb
      0
      • 🚀🚀🚀🚀🚀
        0
        • 🚀
          0
          • February $20 and then FDA approval comes
            0
            • Under accumulation daily, will be FDA approved in February. $25
              0
              • What do you think about price target annouced at 20$ ?
                0
                • kgkg too but Pura has that patented technology!!!
                  0
                  • Puration Inc. look up on investorshub.com. wsj.com has it too
                    0
                    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.